Eric S Wise1, Stephen P Gadomski2, William G McMaster1, Robert J Wilson1, Justin K Nelms3, Kyle M Hocking1, Colleen M Brophy4. 1. Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2730, USA. 2. Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. 3. Department of Surgery, University of Maryland, Baltimore Washington Medical Center, Glen Burnie, MD 21061, USA. 4. Department of Surgery, Tennessee Valley Veterans Administration, Nashville, TN 37212, USA; Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2730, USA.
Abstract
AIMS: This study characterizes the influence of genotype at two loci on warfarin response after arthroplasty. METHODS: 121 postarthroplasty patients given warfarin thromboprophylaxis were reviewed for international normalized ratio (INR) values on the first three days postoperatively. Significant differences among genotypes in INR values on each of the first three postoperative days were assessed. RESULTS: Wild-type patients at both loci (∼23% of patients) had yet to reach therapeutic INR (1.5-2.0) by postoperative day three more frequently than those with a mutation conferring hyper-responsiveness (61% vs. 30%; P ≤ .01). CONCLUSIONS: Wild-type patients are not anticoagulated in a sufficiently prompt manner after arthroplasty.
AIMS: This study characterizes the influence of genotype at two loci on warfarin response after arthroplasty. METHODS: 121 postarthroplasty patients given warfarin thromboprophylaxis were reviewed for international normalized ratio (INR) values on the first three days postoperatively. Significant differences among genotypes in INR values on each of the first three postoperative days were assessed. RESULTS: Wild-type patients at both loci (∼23% of patients) had yet to reach therapeutic INR (1.5-2.0) by postoperative day three more frequently than those with a mutation conferring hyper-responsiveness (61% vs. 30%; P ≤ .01). CONCLUSIONS: Wild-type patients are not anticoagulated in a sufficiently prompt manner after arthroplasty.
Entities:
Keywords:
Arthroplasty; Deep venous thrombosis; Genetics; Thromboprophylaxis; Warfarin
Authors: Majid Moridani; Lei Fu; Rita Selby; Francisco Yun; Tatjana Sukovic; Betty Wong; David E C Cole Journal: Clin Biochem Date: 2006-04-21 Impact factor: 3.281
Authors: Gwendolyn A McMillin; Roberta Melis; Andrew Wilson; Michael B Strong; Nathan A Wanner; Russell G Vinik; Christopher L Peters; Robert C Pendleton Journal: Ther Drug Monit Date: 2010-06 Impact factor: 3.681
Authors: Kristin W Weitzel; Amanda R Elsey; Taimour Y Langaee; Benjamin Burkley; David R Nessl; Aniwaa Owusu Obeng; Benjamin J Staley; Hui-Jia Dong; Robert W Allan; J Felix Liu; Rhonda M Cooper-Dehoff; R David Anderson; Michael Conlon; Michael J Clare-Salzler; David R Nelson; Julie A Johnson Journal: Am J Med Genet C Semin Med Genet Date: 2014-03-10 Impact factor: 3.908
Authors: P A Lenzini; G R Grice; P E Milligan; M B Dowd; S Subherwal; E Deych; C S Eby; C R King; R M Porche-Sorbet; C V Murphy; R Marchand; E A Millican; R L Barrack; J C Clohisy; K Kronquist; S K Gatchel; B F Gage Journal: J Thromb Haemost Date: 2008-07-24 Impact factor: 5.824
Authors: Norman A Johanson; Paul F Lachiewicz; Jay R Lieberman; Paul A Lotke; Javad Parvizi; Vincent Pellegrini; Theodore A Stringer; Paul Tornetta; Robert H Haralson; William C Watters Journal: J Am Acad Orthop Surg Date: 2009-03 Impact factor: 3.020
Authors: Ute I Schwarz; Marylyn D Ritchie; Yuki Bradford; Chun Li; Scott M Dudek; Amy Frye-Anderson; Richard B Kim; Dan M Roden; C Michael Stein Journal: N Engl J Med Date: 2008-03-06 Impact factor: 91.245